• Novogen (NASDAQ:KZIA) Trading Down 0.8% – Here’s What Happened Defense World Thu, 13 Nov 2025 08:20:13 GMT
• kazia therapeutics reveals 100% response rate in interim data from brain metastases drug trial new.smallcaps.com.au Fri, 31 Oct 2025 04:18:45 GMT
• kazia therapeutics awarded us fda rare drug designation for paxalisib in childhood brain cancer new.smallcaps.com.au Fri, 31 Oct 2025 04:18:45 GMT
• kazia therapeutics adds recruitment sites to paxalisib arm of global glioblastoma study new.smallcaps.com.au Fri, 31 Oct 2025 04:18:45 GMT
• Angelini signs $550M deal for Sovargen’s ASO drug in epilepsy BioWorld MedTech Wed, 29 Oct 2025 07:00:00 GMT
• h.c. wainwright maintains kazia therapeutics(kzia.us) with buy rating, maintains target price $13 富途牛牛 Tue, 28 Oct 2025 10:33:00 GMT
• Kazia Therapeutics stock seeks FDA guidance on paxalisib approval path Investing.com Tue, 28 Oct 2025 07:00:00 GMT
• Buy Rating for Kazia Therapeutics Driven by Promising Paxalisib Developments and Regulatory Catalysts TipRanks Tue, 28 Oct 2025 07:00:00 GMT
• Maxim Group Maintains Kazia Therapeutics(KZIA.US) With Buy Rating, Maintains Target Price $20 富途牛牛 Tue, 28 Oct 2025 07:00:00 GMT
• buy rating for kazia therapeutics driven by strategic drug approval and licensing initiatives TipRanks Tue, 28 Oct 2025 07:00:00 GMT
• kazia to seek fda feedback on paxalisib for glioblastoma treatment by investing.com Investing.com Philippines Tue, 28 Oct 2025 02:49:54 GMT
• Kazia to seek FDA feedback on paxalisib for glioblastoma treatment By Investing.com Investing.com Nigeria Mon, 27 Oct 2025 12:06:12 GMT
• kzia plans follow-up meeting with fda to discuss glioblastoma tr GuruFocus Mon, 27 Oct 2025 11:57:21 GMT
• Kazia Therapeutics to Request FDA Type C Meeting to Discuss Overall Survival Data in GBM and Potential NDA Filing in Alignment wit... Yahoo Finance Mon, 27 Oct 2025 07:00:00 GMT
• Kazia (NASDAQ: KZIA) to request FDA Type C on GBM OS; NDA path under review Stock Titan Mon, 27 Oct 2025 07:00:00 GMT
• novogen (nasdaq:kzia) stock price down 4.2% – what’s next? Defense World Wed, 22 Oct 2025 06:40:59 GMT
• Strategic Advancements and Potential in Oncology: Kazia Therapeutics’ Buy Rating Driven by Novel PD-L1 Degrader and AI-Driven Paxa... TipRanks Sat, 11 Oct 2025 07:00:00 GMT
• maxim group maintains kazia therapeutics(kzia.us) with buy rating, maintains target price $20 富途牛牛 Sat, 11 Oct 2025 07:00:00 GMT
• QIMR Berghofer Science Powers Breakthrough In Cancer Immunotherapy Mirage News Wed, 08 Oct 2025 07:00:00 GMT
• qimr berghofer science powers breakthrough in cancer immunotherapy Mirage News Tue, 07 Oct 2025 21:58:00 GMT
• kazia (kzia) secures pd-l1 degrader ndl2 with $1.39m payment Stock Titan Tue, 07 Oct 2025 21:17:39 GMT
• Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program Yahoo Finance Tue, 07 Oct 2025 07:00:00 GMT
• Kazia Therapeutics signs deal for novel cancer immunotherapy asset Investing.com Tue, 07 Oct 2025 07:00:00 GMT
• kazia therapeutics partners with qimr berghofer for innovative pd-l1 degrader program TipRanks Tue, 07 Oct 2025 07:00:00 GMT
• kzia forms strategic partnership for innovative cancer treatment GuruFocus Tue, 07 Oct 2025 07:00:00 GMT
• kazia therapeutics signs collaboration and in-licensing agreement for pd-l1 TipRanks Tue, 07 Oct 2025 07:00:00 GMT
• PI3K Inhibitors Clinical Trials Analysis 2025: Pipeline Analysis, Competitive Landscape, Emerging Therapies, Companies, and Future... The Globe and Mail Mon, 06 Oct 2025 07:00:00 GMT
• maxim group maintains kazia therapeutics(kzia.us) with buy rating, maintains target price $20 富途牛牛 Sat, 04 Oct 2025 12:31:00 GMT
• maxim group issues positive forecast for novogen (nasdaq:kzia) stock price Defense World Sat, 04 Oct 2025 08:01:37 GMT
• maxim group maintains kazia therapeutics(kzia.us) with buy rating, maintains target price $20 富途牛牛 Fri, 03 Oct 2025 15:14:00 GMT
• Case Study Highlights Tumor Burden Reduction With Paxalisib Combo in Metastatic TNBC OncLive Fri, 03 Oct 2025 07:00:00 GMT
• angelini signs $550m deal for sovargen’s aso drug in epilepsy BioWorld MedTech Fri, 03 Oct 2025 07:00:00 GMT
• kazia therapeutics price target raised to $20 from $15 at maxim TipRanks Thu, 02 Oct 2025 13:29:28 GMT
• 86% Tumor Reduction: Kazia's Experimental Cancer Drug Paxalisib Shows Dramatic Results in TNBC Patient Study Stock Titan Thu, 02 Oct 2025 07:00:00 GMT
• Kazia Therapeutics Announces 86% Reduction in Tumor Burden in Expanded-Access Case of Metastatic TNBC Patient Treated with Paxalis... Yahoo Finance Thu, 02 Oct 2025 07:00:00 GMT
• KZIA Stock: Maxim Group Raises Price Target to $20, Maintains Bu GuruFocus Thu, 02 Oct 2025 07:00:00 GMT
• kazia reports 86% tumor reduction in expanded access case Investing.com Thu, 02 Oct 2025 07:00:00 GMT
• kazia therapeutics reports significant tumor reduction in tnbc patient with paxalisib TipRanks Thu, 02 Oct 2025 07:00:00 GMT
• kazia therapeutics (kzia) achieves significant tumor reduction i GuruFocus Thu, 02 Oct 2025 07:00:00 GMT
• kazia therapeutics’ paxalisib combination shows tumor reduction TipRanks Thu, 02 Oct 2025 07:00:00 GMT
• maxim group maintains kazia therapeutics(kzia.us) with buy rating, raises target price to $20 富途牛牛 Thu, 02 Oct 2025 07:00:00 GMT
• Kazia Therapeutics Supports Australian MRFF-Funded Project Developing AI-Driven Sequential Therapy Strategy for DIPG/DMG Yahoo Finance Wed, 01 Oct 2025 07:00:00 GMT
• Revolutionary AI Platform to Combat 25% of Childhood Brain Cancer Deaths: Kazia's New Research Initiative Stock Titan Wed, 01 Oct 2025 07:00:00 GMT
• maxim group maintains kazia therapeutics(kzia.us) with buy rating, maintains target price $15 富途牛牛 Sat, 13 Sep 2025 14:31:00 GMT
• buy rating for kazia therapeutics driven by promising paxalisib developments in cancer treatment TipRanks Sat, 13 Sep 2025 07:00:00 GMT
• kazia therapeutics achieves breakthrough in breast cancer treatment with paxalisib The Globe and Mail Fri, 12 Sep 2025 07:00:00 GMT
• kazia therapeutics soars as breast cancer therapy disrupts tumor cell clusters TradingView Thu, 11 Sep 2025 12:16:44 GMT
• 100% cancer cell cluster elimination: kazia's breakthrough drug shows perfect score in advanced breast cancer Stock Titan Thu, 11 Sep 2025 07:00:00 GMT
• kazia therapeutics reports complete ex vivo disruption of large circulating tumor cell clusters in stage iv her2-positive breast c... Yahoo Finance Thu, 11 Sep 2025 07:00:00 GMT
• kazia therapeutics achieves breakthrough in breast cancer treatment with paxalisib TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• kazia therapeutics’ paxalisib monotherapy shows tumor cell cluster disruption TipRanks Thu, 11 Sep 2025 07:00:00 GMT
• kazia says glioblastoma trial data won’t support fda accelerated nod for lead drug MSN Wed, 10 Sep 2025 07:14:27 GMT
• Leptomeningeal Metastases Market to Exhibit Growth at a GlobeNewswire Tue, 09 Sep 2025 07:00:00 GMT
• head to head contrast: novogen (nasdaq:kzia) & windtree therapeutics (nasdaq:wint) Defense World Fri, 22 Aug 2025 05:43:48 GMT
• novogen limited (nasdaq:kzia) sees large growth in short interest Defense World Mon, 04 Aug 2025 06:14:56 GMT
• Kazia Secures $2M Premium-Priced Investment for Cancer Drug Trials | KZIA Stock News Stock Titan Fri, 01 Aug 2025 07:00:00 GMT
• Kazia Therapeutics Announces $2 Million Private Placement at Premium to Market 富途牛牛 Fri, 01 Aug 2025 07:00:00 GMT
• kazia therapeutics secures $2 million in private placement to advance oncology programs TipRanks Fri, 01 Aug 2025 07:00:00 GMT
• kazia therapeutics raises $2m in private placement of equity securities. AInvest Fri, 01 Aug 2025 07:00:00 GMT
• healthcare stocks move in pre-market session: bioxcel therapeutics, 4d molecular therapeutics, kazia therapeutics, and more. AInvest Fri, 01 Aug 2025 07:00:00 GMT
• kazia therapeutics shares fall 5.26% after-hours following a $2 million private placement announcement. AInvest Fri, 01 Aug 2025 07:00:00 GMT
• kzia issues 14.2m shares, warrants; files f-1 resale registration Stock Titan Fri, 01 Aug 2025 07:00:00 GMT
• kazia therapeutics raises us$2m via discounted private placement to fund trials | kzia sec filing - form 6-k Stock Titan Fri, 01 Aug 2025 07:00:00 GMT
• kazia therapeutics secures $2 million in private placement to advance oncology programs TipRanks Thu, 31 Jul 2025 07:00:00 GMT
• kazia therapeutics shares fall 9.37% intraday after reporting early efficacy data from phase 1b trial. AInvest Mon, 28 Jul 2025 07:00:00 GMT
• kazia therapeutics announces at the market offering agreement The Globe and Mail Sat, 26 Jul 2025 07:00:00 GMT
• novogen (nasdaq:kzia) raised to hold at wall street zen Defense World Sat, 26 Jul 2025 06:49:38 GMT
• kazia therapeutics announces at the market offering agreement TipRanks Fri, 25 Jul 2025 07:00:00 GMT
• kazia therapeutics starts us$1.9m atm ads program; ceo exits board | kzia sec filing - form 6-k Stock Titan Fri, 25 Jul 2025 07:00:00 GMT
• novogen (nasdaq:kzia) raised to “sell” at wall street zen ETF Daily News Mon, 14 Jul 2025 07:00:00 GMT
• novogen (nasdaq:kzia) upgraded by wall street zen to “sell” rating Defense World Sat, 12 Jul 2025 10:55:42 GMT
• novogen (nasdaq:kzia) upgraded by hc wainwright to strong-buy rating Defense World Sat, 12 Jul 2025 09:55:18 GMT
• hc wainwright upgrades novogen (nasdaq:kzia) to strong-buy Defense World Sat, 12 Jul 2025 09:55:18 GMT
• novogen (nasdaq:kzia) rating increased to strong-buy at hc wainwright Defense World Sat, 12 Jul 2025 07:00:00 GMT
• h.c. wainwright maintains kazia therapeutics(kzia.us) with buy rating, cuts target price to $13 富途牛牛 Fri, 11 Jul 2025 07:00:00 GMT
• kazia therapeutics target adjusted to $13 from $2 at h.c. wainwright TipRanks Thu, 10 Jul 2025 10:24:29 GMT
• Kazia Therapeutics stock price target raised to $13 from $2 at H.C. Wainwright Investing.com Thu, 10 Jul 2025 07:00:00 GMT
• cancer innovation accelerates as funding cuts loom and biotechs step up The Globe and Mail Thu, 10 Jul 2025 07:00:00 GMT
• h.c. wainwright maintains kazia therapeutics(kzia.us) with buy rating, cuts target price to $13 富途牛牛 Thu, 10 Jul 2025 07:00:00 GMT
• promising clinical developments and financial adjustments drive buy rating for kazia therapeutics TipRanks Thu, 10 Jul 2025 07:00:00 GMT
• novogen (nasdaq:kzia) shares up 39.7% – should you buy? Defense World Thu, 10 Jul 2025 06:23:55 GMT
• kazia reports promising early data from cancer drug combination trial by investing.com Investing.com South Africa Thu, 10 Jul 2025 05:23:10 GMT
• ryde group files us$100 m shelf; micro-cap float limits near-term raise | kzia sec filing - form 424b3 Stock Titan Wed, 09 Jul 2025 20:07:01 GMT
• kazia therapeutics reports preliminary results from phase 1b trial TipRanks Wed, 09 Jul 2025 12:40:23 GMT
• Kazia Therapeutics stock soars after positive early cancer treatment data Investing.com Wed, 09 Jul 2025 07:00:00 GMT
• Kazia Therapeutics Reports Early Efficacy Data from First Triple-Negative Breast Cancer Patient Receiving Paxalisib Combination Re... Yahoo Finance Wed, 09 Jul 2025 07:00:00 GMT
• Kazia Reports Over 50% Cancer Cell Reduction In Early Data From Breast Cancer Trial, Stock Jumps Yahoo Finance Wed, 09 Jul 2025 07:00:00 GMT
• Early Clinical Trial: New Drug Combo Slashes Breast Cancer Cells by 50% in Just 21 Days Stock Titan Wed, 09 Jul 2025 07:00:00 GMT
• Kazia Therapeutics Announces Promising Early Results in Breast Cancer Trial TipRanks Wed, 09 Jul 2025 07:00:00 GMT
• Kazia reports promising early data from cancer drug combination trial Investing.com Wed, 09 Jul 2025 07:00:00 GMT
• why is kazia stock soaring today - kazia therapeutics (nasdaq:kzia) Benzinga Wed, 09 Jul 2025 07:00:00 GMT
• kazia therapeutics soars 74.8% on promising cancer trial results AInvest Wed, 09 Jul 2025 07:00:00 GMT
• kazia therapeutics (kzia) resumes trading with new developments GuruFocus Mon, 23 Jun 2025 18:22:39 GMT
• kzia trading halted due to volatility pause | kzia stock news GuruFocus Mon, 23 Jun 2025 07:00:00 GMT
• kazia therapeutics announces first patient dosed in phase 1b trial of paxalisib in advanced breast cancer Aktiellt Sat, 21 Jun 2025 08:10:52 GMT
• short interest in novogen limited (nasdaq:kzia) declines by 28.0% Defense World Fri, 20 Jun 2025 07:00:00 GMT
• dauntless investment group, llc acquires shares in kazia therape GuruFocus Wed, 18 Jun 2025 07:00:00 GMT
• dauntless investment group, llc acquires shares in kazia therapeutics ltd GuruFocus Tue, 17 Jun 2025 07:00:00 GMT
• Kazia Therapeutics First Half 2025 Earnings: AU$12.29 loss per share (vs AU$18.40 loss in 1H 2024) Yahoo Finance Fri, 13 Jun 2025 07:00:00 GMT
• kazia therapeutics announces transformative preclinical data demonstrating paxalisib's potential to overcome immunotherapy resista... StreetInsider Thu, 12 Jun 2025 09:55:55 GMT
• buy rating for kazia therapeutics driven by promising paxalisib data and strategic developments TipRanks Thu, 12 Jun 2025 07:00:00 GMT
• kazia therapeutics (nasdaq:kzia) receives buy rating from maxim group Defense World Thu, 12 Jun 2025 07:00:00 GMT
• kazia therapeutics trading halted, volatility trading pause TipRanks Wed, 11 Jun 2025 15:20:35 GMT
• Kazia Therapeutics Announces Transformative Preclinical Data Demonstrating Paxalisib's Potential to Overcome Immunotherapy Resista... PR Newswire Wed, 11 Jun 2025 07:00:00 GMT
• Breakthrough: New Drug Paxalisib Successfully Combats Triple-Negative Breast Cancer Resistance in Preclinical Study Stock Titan Wed, 11 Jun 2025 07:00:00 GMT
• KZIA: Kazia Therapeutics Maintains Buy Rating with $15 PT | KZIA Stock News GuruFocus Wed, 11 Jun 2025 07:00:00 GMT
• Kazia Therapeutics (KZIA) Experiences Trading Halt Due to Volati GuruFocus Wed, 11 Jun 2025 07:00:00 GMT
• Unexpected Stock Surge: What’s Lifting Kazia Therapeutics? timothysykes.com Wed, 11 Jun 2025 07:00:00 GMT
• Kazia Therapeutics Unveils Promising Preclinical Data for Paxalisib in Breast Cancer TipRanks Wed, 11 Jun 2025 07:00:00 GMT
• KZIA Trading Resumes: Kazia Therapeutics Back in Action | KZIA S GuruFocus Wed, 11 Jun 2025 07:00:00 GMT
• Kazia’s paxalisib shows promise in breast cancer preclinical study By Investing.com Investing.com UK Wed, 11 Jun 2025 07:00:00 GMT
• kzia: kazia therapeutics reveals promising preclinical paxalisib research | kzia stock news GuruFocus Wed, 11 Jun 2025 07:00:00 GMT
• kazia therapeutics announces publication of preclinical research on paxalisib TipRanks Wed, 11 Jun 2025 07:00:00 GMT
• kazia therapeutics (kzia) stock surges 77% on positive preclinical data for breast cancer drug Benzinga Wed, 11 Jun 2025 07:00:00 GMT
• kazia therapeutics (kzia) skyrockets on game-changing breast cancer breakthrough—what’s driving the surge? RagingBull Wed, 11 Jun 2025 07:00:00 GMT
• small-cap disruptors kzia, snyr, hsdt, trnr, prso lead momentum – more microcap stocks inside FinancialContent Wed, 11 Jun 2025 07:00:00 GMT
• kazia therapeutics says preclinical data show paxalisib's potential in reducing breast cancer symptoms; shares jump MarketScreener Wed, 11 Jun 2025 07:00:00 GMT
• Kazia Therapeutics Reports Half-Year Financials Amidst Ongoing Drug Development TipRanks Tue, 10 Jun 2025 07:00:00 GMT
• kazia therapeutics reports half-year financials amidst ongoing drug development TipRanks Mon, 09 Jun 2025 07:00:00 GMT
• kazia therapeutics initiates phase 1b trial of paxalisib in advanced breast cancer MSN Sat, 07 Jun 2025 06:00:15 GMT
• kazia therapeutics: strategic advancements and market opportunities reinforce buy rating TipRanks Fri, 06 Jun 2025 07:00:00 GMT
• kazia therapeutics doses first patient in phase 1 trial of paxalisib for advanced breast cancer marketscreener.com Thu, 05 Jun 2025 12:55:24 GMT
• kazia therapeutics (kzia) launches phase 1b trial for advanced breast cancer treatment | kzia stock news GuruFocus Thu, 05 Jun 2025 12:49:25 GMT
• Kazia Therapeutics Announces First Patient Dosed in Phase 1b Trial of Paxalisib in Advanced Breast Cancer PR Newswire Thu, 05 Jun 2025 07:00:00 GMT
• kazia's brain cancer drug now targets breast cancer: first patient starts groundbreaking combination trial Stock Titan Thu, 05 Jun 2025 07:00:00 GMT
• kazia therapeutics initiates phase 1b trial of paxalisib in advanced breast cancer TipRanks Thu, 05 Jun 2025 07:00:00 GMT
• kazia therapeutics says first patient dosed in phase 1b trial of paxalisib TipRanks Thu, 05 Jun 2025 07:00:00 GMT
• kazia therapeutics (nasdaq:kzia) stock price up 26.7% – what’s next? Defense World Wed, 04 Jun 2025 07:00:00 GMT
• analysts are bullish on these healthcare stocks: verastem (vstm), kazia therapeutics (kzia) The Globe and Mail Sat, 24 May 2025 07:00:00 GMT
• transcript : kazia therapeutics limited - shareholder/analyst call marketscreener.com Thu, 22 May 2025 01:05:34 GMT
• glioblastoma drugs market 2034: clinical trials, ema, pdma, fda approvals, medication, statistics, revenue, nice approvals, therap... The Globe and Mail Wed, 21 May 2025 07:00:00 GMT
• transcript : kazia therapeutics limited - shareholder/analyst call MarketScreener Wed, 21 May 2025 07:00:00 GMT
• kazia therapeutics highlights recent progress and provides busin GuruFocus Fri, 16 May 2025 11:48:21 GMT
Kazia Therapeutics Limited(NASDAQ:KZIA) 